ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
TREATMENT FORPROPERTIES/EFFECTSCANNABINOID / TERPENESOURCE (STUDY)SUMMARY OF STUDYRATING
2
ADHDTHC
http://mcforadhd.free.fr/ARTICLE%20ADHD%20DRIVING%20GERMANY.pdf
Thus, it has to be considered, that in the case of ADHD, THC can have a typical effects and can even lead to an enhanced driving related performance.7 STARS
3
Alzheimer's Diseaseanti-inflammatoryTHChttps://www.ncbi.nlm.nih.gov/pubmed/25024327These sets of data strongly suggest that THC could be a potential therapeutic treatment option for Alzheimer's disease through multiple functions and pathways.5 STARS
4
NeuroprotectiveCBD
https://link.springer.com/article/10.1007/s00109-005-0025-1
These results provide new molecular insight regarding the neuroprotective effect of cannabidiol and suggest its possible role in the pharmacological management of AD, especially in view of its low toxicity in humans.
5
ALS ( amyotrophic lateral sclerosis)Potential Medication for ALS CBN
http://www.tandfonline.com/doi/full/10.1080/14660820510030149?scroll=top&needAccess=true
CBN was delivered via subcutaneously implanted osmotic mini‐pumps (5 mg/kg/day) over a period of up to 12 weeks. We found that this treatment significantly delays disease onset by more than two weeks while survival was not affected. Further research is necessary to determine whether non‐psychotropic cannabinoids might be useful in ameliorating symptoms in ALS.5 STARS
6
Amyloidosis SymptomsAntioxidant propertiesAlpha Bisabololhttp://www.sciencedirect.com/science/article/pii/S0928098711002946These findings show that (−)-α-bisabolol is able to decrease oxidative stress and inflammatory event associated with the lesions induced by ethanol.6 STARS
7
Terpineolhttp://www.sciencedirect.com/science/article/pii/S0278691511001487α-Terpineol presented good antioxidant activity in ORAC test.
8
CBGhttps://www.ncbi.nlm.nih.gov/pubmed/28348416Based on its antioxidant activities, CBG may hold great promise as an anti-oxidant agent and therefore used in clinical practice as a new approach in oxidative-stress related disorders.5 STARS
9
http://jpet.aspetjournals.org/content/314/2/780.shortThis study provides the first demonstration of CBD as an in vivo neuroprotectant and shows the efficacy of lipophilic antioxidants in preventing binge ethanol-induced brain injury.
10
Anorexiaimproves appetite and sleep qualityTHChttps://www.ncbi.nlm.nih.gov/pubmed/20824270Dronabinol (Δ(9)tetrahydrocannabinol) is approved for HIV-related anorexia, yet, little is known about its effects in HIV-positive marijuana smokers. HIV-negative marijuana smokers require higher than recommended dronabinol doses to experience expected effects.10 STARS
11
CBD
http://www.neurology.org/content/84/14_Supplement/P6.039.short
These patients illustrate the potential therapeutic use of cannabis in seizure disorders or anorexia. The route of administration (inhaled or buccal) avoids the first-pass effect associated with pill formulations and presents higher levels of cannabinoids such as cannabidiol (CBD) to the endocannabinoid system in the frontal and insular cortex. 7 STARS
12
Appetite Lossboosts appetiteCBNhttps://www.ncbi.nlm.nih.gov/pubmed/22543671This is the first time cannabinol has been shown to increase feeding. Therefore, cannabinol could, in the future, provide an alternative to the currently used and psychotropic ∆(9)-tetrahydrocannabinol-based medicines since cannabinol is currently considered to be non-psychotropic.5 STARS
13
Delta (8)-THC
https://www.ncbi.nlm.nih.gov/pubmed/15099912
Thus, delta(8)-THC (0.001 mg/kg) caused increased food consumption and tendency to improve cognitive function, without cannabimimetic side effects. Hence, a low dose of THC might be a potential therapeutic agent in the treatment of weight disorders.
14
THChttp://www.sciencedirect.com/science/article/pii/S0163725802002577The same effect is observed in animals and in humans with the psychotropic plant cannabinoid Δ9-tetrahydrocannabinol, which is an approved appetite-enhancing drug.
15
Asthmaanti-asthmaAlpha Pinene / Beta Pinenehttp://jamanetwork.com/journals/jama/fullarticle/1104848The oxidation products (OPs) of ozone and the unsaturated hydrocarbons d-limonene, (+)-alpha-pinene, and isoprene have previously been shown to cause upper airway irritation in mice during 30-min acute exposures.

This may be important in the context of the etiology or exacerbation of lower airway symptoms in office workers, or of occupational asthma in workers involved in industrial cleaning operations.
7 STARS
16
https://www.ncbi.nlm.nih.gov/pubmed/12122569The oxidation products (OPs) of ozone and the unsaturated hydrocarbons d-limonene, (+)-alpha-pinene, and isoprene have previously been shown to cause upper airway irritation in mice during 30-min acute exposures.

This may be important in the context of the etiology or exacerbation of lower airway symptoms in office workers, or of occupational asthma in workers involved in industrial cleaning operations.
5 STARS
17
Geraniolhttps://www.ncbi.nlm.nih.gov/pubmed/27117312The oxidation products (OPs) of ozone and the unsaturated hydrocarbons d-limonene, (+)-alpha-pinene, and isoprene have previously been shown to cause upper airway irritation in mice during 30-min acute exposures.

This may be important in the context of the etiology or exacerbation of lower airway symptoms in office workers, or of occupational asthma in workers involved in industrial cleaning operations.
18
ArthritisAntiinflammatoryCBD
http://www.pnas.org/content/97/17/9561.short
Taken together, these data show that CBD, through its combined immunosuppressive and anti-inflammatory actions, has a potent anti-arthritic effect in CIA.5 STARS
19
Autismneutralizes seizures and self-directed rages.THChttps://www.ncbi.nlm.nih.gov/pubmed/21886592These responses appeared to be enhanced by the prototypic cannabinoid, Δ(9)-THC. MDMA and MPTP at the doses used did not modify SWR behavior in the BTBR mice whereas MPTP reduced SWR activity in the control CB57BL/6J mice. In the hippocampus, striatum and frontal cortex, the levels of DA and 5-HT and their metabolites were differentially altered in the BTBR and C57BL/6J mice. Our data provides a basis for further studies in evaluating the role of the cannabinoid and monoaminergic systems in the etiology of ASDs.5 STARS
20
BacteriaAnti-bacterialCBD
https://link.springer.com/article/10.1007%2FBF00399444?LI=true
The minimum inhibiting concentrations (MIC) of Ag-tetrahydrocannabinol (THC) and cannabidiol (CBD) for staphylococci and streptococci in broth are in the range of 1-5 pg/ml. In the same range, both compounds are also bactericidal. 5 STARS
21
CBN
https://www.ncbi.nlm.nih.gov/pubmed/18681481
Marijuana (Cannabis sativa) has long been known to contain antibacterial cannabinoids, whose potential to address antibiotic resistance has not yet been investigated. All five major cannabinoids (cannabidiol (1b), cannabichromene (2), cannabigerol (3b), Delta (9)-tetrahydrocannabinol (4b), and cannabinol (5)) showed potent activity against a variety of methicillin-resistant Staphylococcus aureus (MRSA) strains of current clinical relevance.
22
CBG
http://pubs.acs.org/doi/full/10.1021/np8002673?src=recsys
Evidence that pre-cannabidiol (1a) is a powerful plant antibiotic was, nevertheless, obtained,(4) and more recent investigations have demonstrated, to various degrees, antibacterial activity for the nonpsychotropic cannabinoids cannabichromene (CBC, 2),(5) cannabigerol (CBG, 3b),(6) and cannabidiol (1b),(7) as well as for the psychotropic agent Δ9-tetrahydrocannabinol (THC, 4b).4 STARS
23
Bone related diseasesstimulate bone formationDelta 3 Carenehttp://onlinelibrary.wiley.com/doi/10.1002/ptr.2247/epdfIn conclusion, 3-carene can stimulate mineralizationby the induction of osteoblast mineralization-relatedgenes such as osteopontin and type I collagen thesegenes via the induction/activation of MAP kinases inpart.5 STARS
24
Cancerreduces / kills cancer tumorsborneolhttp://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063502Taken together, these results reveal that NB strongly potentiates SeC-induced apoptosis in cancer cells by enhancement of cellular uptake and activation of ROS-mediated DNA damage. NB could be further developed as a chemosensitizer of SeC in treatment of human cancers.5 STARS
25
CBDhttp://onlinelibrary.wiley.com/doi/10.1016/j.molonc.2014.12.010/full These results also indicate that CBD can be used as a novel therapeutic option to inhibit growth and metastasis of highly aggressive breast cancer subtypes including TNBC, which currently have limited therapeutic options and are associated with poor prognosis and low survival rates.
26
http://jpet.aspetjournals.org/content/308/3/838.short
In conclusion, the nonpsychoactive CBD was able to produce a significant antitumor activity both in vitro and in vivo, thus suggesting a possible application of CBD as an antineoplastic agent.
27
CBDAhttp://www.sciencedirect.com/science/article/pii/S0378427412012854The data presented in this report suggest for the first time that as an active component in the cannabis plant, CBDA offers potential therapeutic modality in the abrogation of cancer cell migration, including aggressive breast cancers.
28
CBGhttps://link.springer.com/article/10.1007/BF02975301Cannabigerol (3) exhibited the highest growth-inhibitory activity against the cancer cell lines.
29
https://link.springer.com/article/10.1007%2FBF02976895?LI=true
Cannabigerol(3) was synthesized and evaluated for its inhibitory activity against mouse skin melanoma cells. Cannabigerol displayed significant antitumor activity [inhibitory concentration (IC50)=31.3l μ/mL]in vitro assay.
30
Terpinolenehttps://www.degruyter.com/view/j/aiht.2013.64.issue-3/10004-1254-64-2013-2365/10004-1254-64-2013-2365.xmlOur findings clearly demonstrate that TPO is a potent antiproliferative agent for brain tumour cells and may have potential as an anticancer agent
31
Terpineolhttps://www.ncbi.nlm.nih.gov/pubmed/21540069Thus, antioxidant potential of three monoterpenoids (carvone, perillyl alcohol, and α-terpineol) was measured using two methods: DPPH and ORAC. Also, the antiproliferative effect of these monoterpenoids against nine cancerous cell lines were performed and compared to limonene and doxorubicin. Results showed that all samples tested had very low antioxidant activity in the DPPH assay, but α-terpineol (2.72μmolTrolox equiv./μmol) could be compared to commercial antioxidants in the ORAC assay.6 STARS
32
THChttps://www.ncbi.nlm.nih.gov/pubmed/6985702?dopt=AbstractWe conclude that THC is an effective antiemetic in many patients who receive chemotherapy for cancer and for whom other antiemetics are ineffective. (N Engl J Med 302:135--138, 1980).10 STARS
33
CachexiaEnhance appetiteTHC
http://europepmc.org/abstract/med/9208884
Use of progestogens (megesterol acetate, medroxyprogesterone), corticosteroids (decadron, prednisone), metoclopramide, tetrahydrocannabinol (dronabinol), and possibly anabolic steroids (nandrolone decanoate, oxandrolone), melatonin, and eicosapentaenoic acid, may yield therapeutic benefit.5 STARS
34
Chronic illness (HIV)enhance appetiteTHChttps://www.ncbi.nlm.nih.gov/pubmed/15857739In obese humans, it causes weight reduction. Very little is known about the physiological and biochemical mechanisms involved in the effects of Δ9-tetrahydrocannabinol and the cannabinoids in feeding and appetite.7 STARS
35
http://www.sciencedirect.com/science/article/pii/S0163725802002577In obese humans, it causes weight reduction. Very little is known about the physiological and biochemical mechanisms involved in the effects of Δ9-tetrahydrocannabinol and the cannabinoids in feeding and appetite.5 STARS
36
Colitis / Ulcerative Colitisrelieves the pain and inflammationCBGhttp://www.sciencedirect.com/science/article/pii/S0168365903004152In conclusion, ethosomes enable CBD's skin permeation and its accumulation in a depot at levels that demonstrate the potential of transdermal CBD to be used as an anti-inflammatory treatment.5 STARS
37
https://www.ncbi.nlm.nih.gov/pubmed/22163000Our results therefore indicate that CBD indeed unravels a new therapeutic strategy to treat inflammatory bowel diseases.
38
Crohn's Diseaselimits intestinal inflammationTHChttps://www.ncbi.nlm.nih.gov/pubmed/23648372Although the primary end point of the study (induction of remission) was not achieved, a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn's disease, compared with placebo, without side effects.9 STARS
39
Depressionstabilize moods and ease depressionCaryophyllenehttps://www.ncbi.nlm.nih.gov/pubmed/24930711Most importantly, pre-administration of the CB2 receptor antagonist AM630, fully abrogated the anxiolytic and the anti-depressant effects of BCP. Taken together, these preclinical results suggest that CB2 receptors may provide alternative therapeutic targets for the treatment of anxiety and depression. The possibility that BCP may ameliorate the symptoms of these mood disorders offers exciting prospects for future studies.5 STARS
40
CBD
https://www.ncbi.nlm.nih.gov/pubmed/27010632
These results suggest that CBD may be beneficial for the treatment of clinical depression and other states with prominent anhedonia.
41
http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2009.00521.x/full
BD (30 mg·kg−1) treatment reduced immobility time in the forced swimming test, as did the prototype antidepressant imipramine, without changing exploratory behaviour in the open field arena.
42
CBGhttps://www.ncbi.nlm.nih.gov/pubmed/27010632These results suggest that CBD may be beneficial for the treatment of clinical depression and other states with prominent anhedonia.
43
https://www.ncbi.nlm.nih.gov/pubmed/28348416
Based on its antioxidant activities, CBG may hold great promise as an anti-oxidant agent and therefore used in clinical practice as a new approach in oxidative-stress related disorders.
44
Linaloolhttps://www.researchgate.net/publication/273480273_Linalool_and_b-pinene_exert_their_antidepressant-like_activity_through_the_monoaminergic_pathwayOur results indicate that linalool and β-pinene produce an antidepressant-like effect through interaction with the monoaminergic system.
45
THC
http://www.sciencedirect.com/science/article/pii/S0091305710000730
Results of this study show that ∆9-THC and other cannabinoids exert antidepressant-like actions, and thus may contribute to the overall mood-elevating properties of cannabis.
46
Diabetesregulate production of insulinCBGhttps://www.ncbi.nlm.nih.gov/pubmed/27767974Cannabidiol (CBD), a phytocannabinoid, derived from the plant, Cannabis sativa, was shown to lower the incidence of diabetes in non-obese diabetic (NOD) mice, an animal model of spontaneous T1D development.5 STARS
47
THCVhttp://care.diabetesjournals.org/content/39/10/1777THCV could represent a new therapeutic agent in glycemic control in subjects with type 2 diabetes.10 STARS
48
Dystoniaimporoves conditionCBDhttps://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=142&&search_pattern=movement,disorderWe report the effect of CBD on dystonia secondary to Sinemet in parkinsonism, a DISORDER thought to be a relative contraindication for cannabinoids (D.Moss et al, Pharmacol Biochem Behav 1981, 1984). The patient, a 42-year- old man with an 8-year history of parkinsonism, developed peak-dose dyskinesia about 4 years ago and action dystonia affecting all limbs more recently. Trihexyphenidyl and bromocriptine each produced only slight improvement.10 STARS
49
eliminate nightmaresreduce stress, tension and anxietyCBDhttps://www.nature.com/npp/journal/v36/n6/full/npp20116a.htmlThe increase in anxiety induced by the SPST on subjects with SAD was reduced with the use of CBD, resulting in a similar response as the HC.8 STARS
50
Linaloolhttp://www.sciencedirect.com/science/article/pii/S0091305711002954These results suggest that inhalation of linalool oxide may be a useful means of counteracting anxiety.5 STARS
51
Epilepsyregulate seizureCBD
http://www.sciencedirect.com/science/article/pii/S105913111200057X
In the penicillin model, CBD (≥10 mg/kg) significantly decreased the percentage mortality as a result of seizures; CBD (all doses) also decreased the percentage of animals experiencing the most severe tonic–clonic seizures. 5 STARS
52
CBN
http://www.sciencedirect.com/science/article/pii/0024320574900095
The four principal naturally occurring cannabinoids, Δ9-THC, Δ8-THC, cannabinol and cannabidiol, display anticonvulsant activity, as does the major, primary metabolite of Δ9-THC, 11-hydroxy-Δ9-THC.
53
CBDVhttps://peerj.com/articles/214/#fig-5Overall, we provide molecular evidence that directly supports behavioural evidence that CBDV exerts significant anticonvulsant effects via oral and other routes of administration
54
Linaloolhttp://www.academia.edu/13393321/Anticonvulsant_properties_of_linalool_in_glutamate-related_seizure_modelsConsidering that linalool is a major component of plant based anticonvulsant remedies used in traditional medicinal systems, and the indication of multiple mechanisms of action relevant for decreasing neuronal excitability, further investigation on linalool as a potential anticonvulsant drug are desired.
55
Gastrointestinal Disordersreduced acid reflux / protection from inflammationTHC
http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2036.1999.00441.x/full
It has been reported that THC inhibits gastrointestinal motility in mice.11, 12 Our present findings in humans would also suggest this and support the concept that one of THC’s peripheral effects is to inhibit gastrointestinal smooth muscle actio10 STARS
56
CBD
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2008.01114.x/full
Cannabidiol further reduced gastrointestinal motility in septic mice but did not affect gastrointestinal motility in control mice. 5 STARS
57
Isopulegolhttps://www.ncbi.nlm.nih.gov/pubmed/19479241The results suggested that isopulegol presents significant gastroprotective effects in both ethanol- and indomethacin-induced ulcer models, which appear to be mediated, at least in part, by endogenous prostaglandins, K(ATP) channel opening, and antioxidant properties.
58
Limonenehttps://www.ncbi.nlm.nih.gov/pubmed/24328705We concluded that OEC and LIM, two common flavoring agents, promote gastric mucosal healing without any apparent toxic effect, resulting in better gastric epithelial organization in the treated rats.
59
analgesicCBD
http://www.sciencedirect.com/science/article/pii/S0014299904012348
We conclude that centrally inactive (+)-cannabidiol analogues should be further developed as antidiarrheal, antiinflammatory and analgesic drugs for gastrointestinal and other peripheral conditions.
60
Glaucomareduced Intraocular pressureCBDhttps://www.ncbi.nlm.nih.gov/pubmed/16988594A single 5 mg sublingual dose of Delta-9-THC reduced the IOP temporarily and was well tolerated by most patients. Sublingual administration of 20 mg CBD did not reduce IOP, whereas 40 mg CBD produced a transient increase IOP rise.10 STARS
61
increased retinal hemodynamicsTHChttps://www.ncbi.nlm.nih.gov/pubmed/17188063Cannabinoids, already known for their ability to reduce IOP, may result in increased retinal hemodynamics. This may be beneficial in ocular circulatory disorders, including glaucoma.8 STARS
62
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1358964/Appropriate patients were treated with either orally administered delta-9-tetrahydrocannabinol capsules or inhaled marijuana in addition to their existing therapeutic regimen.

There is an impression that this treatment can lower intraocular pressure, but the development of tolerance and significant systemic toxicity appears to limit the usefulness of this potential treatment.
63
CBG
http://online.liebertpub.com/doi/abs/10.1089/jop.1990.6.259
These results suggest that cannabigerol and related cannabinoids may have therapeutic potential for the treatment of glaucoma.5 STARS
64
Goutrelieves swelling and inflammationCBDhttp://www.sciencedirect.com/science/article/pii/S0168365903004152In conclusion, ethosomes enable CBD's skin permeation and its accumulation in a depot at levels that demonstrate the potential of transdermal CBD to be used as an anti-inflammatory treatment.5 STARS
65
Huntington’s DiseaseCBG
https://www.nature.com/articles/srep29789?WT.feed_name=subjects_neuroscience
a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease.5 STARS
66
Inflammationreduces inflammation and painAlpha Bisabololhttps://www.ncbi.nlm.nih.gov/pubmed/21771629Our results indicate that (-)-α-bisabolol exerts anti-inflammatory effects by downregulating expression of iNOS and COX-2 genes through inhibition of NF-κB and AP-1 (ERK and p38) signaling.5 STARS
67
Alpha Pinene / Beta Pinenehttp://www.worldscientific.com/doi/abs/10.1142/S0192415X15500457These results indicate that α-pinene has an anti-inflammatory effect and that it is a potential candidate as a new drug to treat various inflammatory diseases.
68
borneolhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300604The study results showed that borneol has anti-inflammatory and healing action in induced oral mucositis in cheek mucosa of Wistar rats.
69
Caryophyllenehttp://www.sciencedirect.com/science/article/pii/S0014299907005419All these findings indicate that α-humulene and (−)-trans-caryophyllene, derived from the essential oil of C. verbenacea, might represent important tools for the management and/or treatment of inflammatory diseases.
70
CBChttp://onlinelibrary.wiley.com/doi/10.1002/j.1552-4604.1981.tb02606.x/fullAntiinflammatory activity was evaluated by the carrageenan-induced rat paw edema and the erythrocyte membrane stabilization method. In both tests, CBC was superior to phenylbutazone. Antibacterial activity of CBC and its isomers and homologs was evaluated using gram-positive, gram-negative, and acid-fast bacteria. Antifungal activity was evaluated using yeastlike and filamentous fungi and a dermatophyte. Antibacterial activity was strong, and the antifungal activity was mild to moderate.
71
CBGhttp://www.sciencedirect.com/science/article/pii/S0168365903004152In conclusion, ethosomes enable CBD's skin permeation and its accumulation in a depot at levels that demonstrate the potential of transdermal CBD to be used as an anti-inflammatory treatment.
72
Delta 3 Carenehttps://www.ncbi.nlm.nih.gov/pubmed/2747263The essential oil of Bupleurum gibraltaricum showed considerable anti-inflammatory activity against carrageenan-produced pedal edema in rats. This appeared to be due to the delta-3-carene component.
73
Humulenehttp://www.sciencedirect.com/science/article/pii/S0014299907005419All these findings indicate that α-humulene and (−)-trans-caryophyllene, derived from the essential oil of C. verbenacea, might represent important tools for the management and/or treatment of inflammatory diseases
74
Linaloolhttp://www.sciencedirect.com/science/article/pii/S0022480412009699The results suggest that linalool inhibits inflammation both in vitro and in vivo, and may be a potential therapeutic candidate for the treatment of inflammatory diseases.
75
NADA
http://www.jimmunol.org/content/172/4/2341.short
These findings provide new mechanistic insights into the anti-inflammatory activities of NADA and highlight their potential to design novel therapeutic strategies to manage inflammatory diseases.
76
THC
http://www.sciencedirect.com/science/article/pii/0014299973901076
The oral anti-inflammatory efficacy of Δ9-THC was compared to phenylbutazone and acetylsalicylic acid.
77
CBGA
https://www.jstage.jst.go.jp/article/bpb/34/5/34_5_774/_pdf
Anti-inflammatory activity (i.e., inhibition of COX-2) is proposed to play an important role in the development of colon cancer, which makes this subject interesting to study further. In the present work, the six cannabinoids tetrahydrocannabinol (D9 -THC), tetrahydrocannabinolic acid (D9 -THC-A), cannabidiol (CBD), cannabidiolic acid (CBDA), cannabigerol (CBG) and cannabigerolic acid (CBGA), isolated from Cannabis sativa, were evaluated for their effects on prostaglandin production.6 STARS
78
CBDA
http://dmd.aspetjournals.org/content/36/9/1917.short
Nonsteroidal anti-inflammatory drugs containing a carboxyl group in their chemical structures such as salicylic acid are known to inhibit nonselectively both COX-1 and COX-2. CBDA and Δ9-THCA have a salicylic acid moiety in their structures. Thus, the structural requirements for the CBDA-mediated COX-2 inhibition were next studied. There is a structural difference between CBDA and Δ9-THCA; phenolic hydroxyl groups of CBDA are freed from the ring formation with the terpene moiety, although Δ9-THCA has dibenzopyran ring structure.4 STARS
79
Insomnia Reduce AnxietyCBD
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101100/
This case study offers evidence that CBD is effective as a safe alternative treatment to traditional psychiatric medications for reducing anxiety and insomnia.175 STARS
80
Irritable bowel syndromeCBG
http://www.sciencedirect.com/science/article/pii/S0006295213000543
In conclusion, CBG attenuated murine colitis, reduced nitric oxide production in macrophages (effect being modulated by the CB2 receptor) and reduced ROS formation in intestinal epithelial cells. CBG could be considered for clinical experimentation in IBD patients.5 STARS
81
Liver Diseaseimporves sleep / decrease in pruritusTHChttps://www.ncbi.nlm.nih.gov/pubmed/12190187The duration of antipruritic effect is approximately 4-6 hrs in all three patients suggesting the need for more frequent dosing. Delta-9-tetrahydrocannabinol may be an effective alternative in patients with intractable cholestatic pruritus.8 STARS
82
Memory impairmentMedication for Memory impairmentTHC
https://link.springer.com/article/10.1007/BF02246347
Moreover, these results suggest that scopolamine and Δ9-THC do not impair spatial memory in a common serial pathway, though they may converge on a third neurochemical system.5 STARS
83
Anandamide or AEA
http://journals.lww.com/behaviouralpharm/pages/articleviewer.aspx?year=1996&issue=05000&article=00008&type=abstract
This is the first report that anandamide impairs memory; results suggest that endogenous cannabinoids may be involved in cognitive processes influencing memory.
84
Movement Disorderimproves movementsCBDhttps://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=142&&search_pattern=movement,disorderIn idiopathic dystonia, the terapeutic effect of marijuana smoking is reported to be comparable to diazepam (C.D. Marsden, in DISORDERs of MOVEMENT, 1981,81). The non-psychoactive cannabis derivative, cannabidiol (CBD), also improves dystonia (Consroe and Snider, in Cannbinoids as Therapeutic Agents, in press).8 STARS
85
MRSACBChttp://pubs.acs.org/doi/pdf/10.1021/np8002673All five major cannabinoids (cannabidiol (1b), cannabichromene (2), cannabigerol (3b), Δ9-tetrahydrocannabinol (4b), and cannabinol (5)) showed potent activity against a variety of methicillin-resistant Staphylococcus aureus (MRSA) strains of current clinical relevance.4 STARS
86
CBD
87
CBG
88
CBN
89
Multiple Sclerosisreduce muscle spacityCBD
http://www.sciencedirect.com/science/article/pii/S0149291807002949
THC/CBD was effective, with no evidence of tolerance, in these select patients with CNP and MS who completed ∼2 years of treatment (n = 28). 10 STARS
90
THChttp://www.bmj.com/content/329/7460/253?linkType=FULL&journalCode=bmj&resid=329/7460/253(oral synthetic δ-9-tetrahydrocannabinol dronabinol) Oral dronabinol reduced central pain in patients with multiple sclerosis.
91
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394820/Although orally administered cannabinoids failed to improve pain in an uncontrolled study involving 20 patients with multiple sclerosis,17 two placebo-controlled studies10,18 did find a treatment effect. In a trial of a sublingual spray containing delta-9-THC alone or combined with cannabinol, Rog and colleagues reported a 41% reduction in pain, compared with a 22% reduction with placebo.9 STARS
92
NauseaAlleviate nausea and vomitingCBD
http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01621.x/full
These results suggest that CBD produced its anti-emetic/anti-nausea effects by indirect activation of the somatodendritic 5-HT1A autoreceptors in the DRN.5 STARS
93
CBDAhttp://onlinelibrary.wiley.com/doi/10.1111/bph.12043/fullCompared with cannabidiol, CBDA displays significantly greater potency at inhibiting vomiting in shrews and nausea in rats, and at enhancing 5-HT1A receptor activation, an action that accounts for its ability to attenuate conditioned gaping in rats.
94
CBDVhttps://www.ncbi.nlm.nih.gov/pubmed/23902479The pattern of findings indicates that neither THCV nor CBDV produced a behavioural profile characteristic of CB1 receptor inverse agonists. As well, these compounds may have therapeutic potential in reducing nausea.
95
THChttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165951/Cannabinoid agonists (Δ9-THC, HU-210) and the fatty acid amide hydrolase (FAAH) inhibitor, URB-597, suppress conditioned gaping reactions (nausea) in rats as they suppress vomiting in emetic species.
96
https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/600430Tetrahydrocannabinol appears to offer significant control of nausea in most patients and exceeding by far that provided by prochlorperazine.10 STARS
97
THCAhttp://onlinelibrary.wiley.com/doi/10.1111/bph.12316/fullThese data suggest that THCA may be a more potent alternative to THC in the treatment of nausea and vomiting5 STARS
98
THCv
http://onlinelibrary.wiley.com/doi/10.1111/bph.12322/full
The pattern of findings indicates that neither THCV nor CBDV produced a behavioural profile characteristic of CB1 receptor inverse agonists. As well, these compounds may have therapeutic potential in reducing nausea.
99
Neurodegenerative Disorderneuroprotective and antiinflammatoryCBDhttp://jpet.aspetjournals.org/content/314/2/780.shortThis study provides the first demonstration of CBD as an in vivo neuroprotectant and shows the efficacy of lipophilic antioxidants in preventing binge ethanol-induced brain injury.5 STARS
100
https://www.researchgate.net/profile/Jose_Martinez-Orgado/publication/23148432_Neuroprotective_Effects_of_the_Nonpsychoactive_Cannabinoid_Cannabidiol_in_Hypoxic-Ischemic_Newborn_Piglets/links/00b7d538c6d0f32527000000.pdfIn conclusion, administration of CBD after a HI insult in newborn piglets reduced short-term brain damage, in a manner that can be attributed to a CBD-induced reduction of cerebral hemodynamic impairment, improvement of brain metabolic activity postinsult, reduction of brain edema, and reduction of seizures. These neuroprotective effects were not only free from side effects but also associated with some cardiac, hemodynamic, and ventilatory benefits.